New Polymorph Of Ivabradine Hydrochloride And Method For Its Preparation - EP2781509

The patent EP2781509 was granted to Chemo Research on Jun 14, 2023. The application was originally filed on Mar 19, 2014 under application number EP14160639A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2781509

CHEMO RESEARCH
Application Number
EP14160639A
Filing Date
Mar 19, 2014
Status
Patent Maintained As Amended
May 12, 2023
Grant Date
Jun 14, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BOTTI & FERRARIAug 18, 2020FERRECCIOADMISSIBLE

Patent Citations (24) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONEP0534859
DESCRIPTIONUS7176197
DESCRIPTIONUS7384932
DESCRIPTIONUS7867997
DESCRIPTIONWO2008065681
DESCRIPTIONWO2011098582
DESCRIPTIONWO2012025940
DESCRIPTIONWO2013017582
DESCRIPTIONWO2013064307
OPPOSITIONIN201641022049
OPPOSITIONUS2006194962
OPPOSITIONUS2009318417
OPPOSITIONUS2010179316
OPPOSITIONUS2017044108
OPPOSITIONUS7176197
OPPOSITIONWO2011098582
OPPOSITIONWO2013064307
OPPOSITIONWO2013102919
OTHERWO2013064307
OTHERWO2013102919
SEARCHUS2009318417
SEARCHUS2010179316
SEARCHUS7176197
SEARCHWO2011098582

Non-Patent Literature (NPL) Citations (6) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- "Gebzelab Rigaku D-Max 2200 Series X-Ray Diffraction Device", URL: http://gebzelab.gtu.edu.tr/index.php/x-isini-kirinimi-cihazi-ri2aku-d-max-2200-series-
OPPOSITION- International Journal of Pharmaceutics, 92 (1993), 157-166-
OPPOSITION- Jeremy Karl Cockcroft, "Generation of X-rays", (20200707), URL: pd.chem.ucl.ac.uk/pdnn/inst1/xrays.htm, XP055735778-
OPPOSITION- Stephen Byrn et al, "Pharmaceutical Solids: A strategic Approach to Regulatory Considerations", Pharmaceutical Research, (19950000), vol. 12, no. 7, pages 945 - 954-
OPPOSITION- Михаил Викторович Белоусов, Дильшат Файзиевич Ракипов, Мария Петровна Колесникова, Евгения Алексеевна Никоненко, Александр Георгиевич Бисеров, Кирилл Александрович Карасев, "КОМПЛЕКСНОЕ ИССЛЕДОВАНИЕ ДУНИТА С ЦЕЛЬЮ ПОЛУЧЕНИЯ МАГНИЯ И ЕГО СОЕДИНЕНИЙ /Comprehensive study of dunite in order to obtain magnesium and its compound/", Известия высших учебных заведений. Горный журнал, no. 7, (20130000), pages 123 - 127, URL: https://science.urfu.ru/en/publications/%D0%BA%D0%BE%D0%BC%D0%BF%D0%BB%D0%B5%D0%BA%D1%81%D0%BD%D0%BE%D0%B5-%D0%B8%D1%81%D1%81%D0%BB%D0%B5%D0%B4%D0%BE%D0%B2%D0%B0%D0%BD%D0%B8%D0%B5-%D0%B4%D1%83%D0%BD%D0%B8%D1%82%D0%B0-%D1%81-%D1%86%D0%B5%D0%BB%D1%8C%D1%8E-%D0%BF%D0%BE%D0%BB%D1%83%D1%87%D0%B5%D0%BD%D0%B8%D1%8F-%D0%BC%D0%B0%D0%B3%D0%BD%D0%B8%D1%8F-%D0%B8-%D0%B5%D0%B3%D0%BE-%D1%81%D0%BE-
OPPOSITION- Stephen Byrn; Pfeiffer Ralph; Ganey Michael; Hoiberg Charles; Poochikian Guirag, "Pharmaceutical Solids: A strategic Approach to Regulatory Considerations", Pharmaceutical Research, (19950000), vol. 12, no. 7, pages 945 - 954, XP000996386

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents